Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Medtronic
Baxter
Harvard Business School
Merck

Last Updated: January 27, 2023

Atorvastatin calcium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for atorvastatin calcium and what is the scope of patent protection?

Atorvastatin calcium is the generic ingredient in four branded drugs marketed by Accord Hlthcare, Agnitio, Alkem Labs Ltd, Apotex Inc, Biocon Pharma, Dr Reddys, Dr Reddys Labs Ltd, Graviti Pharms, Invagen Pharms, Lannett Co Inc, Lepu Pharm, Lupin Ltd, Micro Labs Ltd India, MSN, Mylan Pharms Inc, Perrigo R And D, Sandoz Inc, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms, Teva Pharms Usa, Umedica Labs Pvt Ltd, Zydus Pharms, Upjohn, Organon, and Scov3, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-five drug master file entries for atorvastatin calcium. Fifty-eight suppliers are listed for this compound.

Drug Sales Revenue Trends for atorvastatin calcium

See drug sales revenues for atorvastatin calcium

Recent Clinical Trials for atorvastatin calcium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stony Brook UniversityPhase 3
Odense Patient Data Explorative NetworkN/A
Odense University HospitalN/A

See all atorvastatin calcium clinical trials

Pharmacology for atorvastatin calcium
Medical Subject Heading (MeSH) Categories for atorvastatin calcium

US Patents and Regulatory Information for atorvastatin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 091650-003 Jul 17, 2012 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mylan Pharms Inc ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 091226-002 May 29, 2012 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Scov3 LYPQOZET atorvastatin calcium; ezetimibe TABLET;ORAL 206084-002 Apr 26, 2017 RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Micro Labs Ltd India ATORVASTATIN CALCIUM atorvastatin calcium TABLET;ORAL 205945-001 Nov 7, 2019 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for atorvastatin calcium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn LIPITOR atorvastatin calcium TABLET;ORAL 020702-004 Apr 7, 2000 See Plans and Pricing See Plans and Pricing
Upjohn LIPITOR atorvastatin calcium TABLET;ORAL 020702-002 Dec 17, 1996 See Plans and Pricing See Plans and Pricing
Upjohn LIPITOR atorvastatin calcium TABLET;ORAL 020702-003 Dec 17, 1996 See Plans and Pricing See Plans and Pricing
Upjohn LIPITOR atorvastatin calcium TABLET;ORAL 020702-002 Dec 17, 1996 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Colorcon
Medtronic
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.